Axplora- The partner of choice for complex APIs.
01 1Finorga
01 1SELINEXOR
01 1Germany
NDC Package Code : 62009-1911
Start Marketing Date : 2019-04-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Selinexor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Selinexor, including repackagers and relabelers. The FDA regulates Selinexor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Selinexor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Selinexor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Selinexor supplier is an individual or a company that provides Selinexor active pharmaceutical ingredient (API) or Selinexor finished formulations upon request. The Selinexor suppliers may include Selinexor API manufacturers, exporters, distributors and traders.
click here to find a list of Selinexor suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Selinexor as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Selinexor API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Selinexor as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Selinexor and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Selinexor NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Selinexor suppliers with NDC on PharmaCompass.
LOOKING FOR A SUPPLIER?